Oxidative stress may play a role in neurologic disease. The present study e
xamined the relation between use of vitamin E and vitamin C and incident Al
zheimer disease in a prospective study of 633 persons 65 years and older. A
stratified random sample was selected from a disease-free population. At b
aseline, all vitamin supplements taken in the previous 2 weeks were identif
ied by direct inspection. After an average follow-up period of 4.3 years, 9
1 of the sample participants with vitamin information met accepted criteria
for the clinical diagnosis of Alzheimer disease. None of the 27 vitamin E
supplement users had Alzheimer disease compared with 3.9 predicted based on
the crude observed incidence among nonusers (p = 0.04) and 2.5 predicted b
ased on age, sex, years of education, and length of follow-up interval (p =
0.23). None of the 23 vitamin C supplement users had Alzheimer disease com
pared with 3.3 predicted based on the crude observed incidence among nonuse
rs (p = 0.10) and 3.2 predicted adjusted for age, sex, education, and follo
w-up, interval (p = 0.04). There was no relation between Alzheimer disease
and use of multivitamins. These data suggest that use of the higher-dose vi
tamin E and vitamin C supplements may lower the risk of Alzheimer disease.